Volume 31, Number 3—March 2025
Dispatch
National Active Case-Finding Program for Tuberculosis in Prisons, Peru, 2024
Table 2
Predictive value of CAD4TB, symptom screening, and sputum testing among participants in a national active case-finding program for TB in prisons, Peru, 2024*
CAD4TB score | Symptoms | No. (%) | Sputum collected | TB confirmed |
||
---|---|---|---|---|---|---|
No. confirmed | % TB cases (95% CI)† | % Sputum positivity (95% CI)‡ | ||||
<40 | ||||||
N | 30,335 (78.3) | 333 | 17 | 1.6 (0.9–2.5) | 5.1 (3.0–8.1) | |
Y |
2,491 (6.4) |
1,250 |
85 |
7.8 (6.3–9.6) |
6.8 (5.5–8.3) |
|
≥40 | ||||||
N | 3,786 (9.8) | 3,642 | 445 | 40.9 (37.9–43.9) | 12.2 (11.2–13.3) | |
Y |
2,122 (5.5) |
2,066 |
542 |
49.8 (46.8–52.8) |
26.2 (24.4–28.2) |
|
Total | 38,734 | 7,291 | 1,089 |
*CAD4TB, Computer-Aided Detection for Tuberculosis version 7.0 (Delft Imaging Systems, https://delft.care); TB, tuberculosis. †TB case defined as any positive or trace result via Xpert MTB/RIF Ultra (Cepheid, https://www.cepheid). ‡Sputum positivity calculated as percentage of individuals with sputum collected who are confirmed to have TB via Xpert MTB/RIF Ultra (Cepheid).
1These senior authors contributed equally to this article.
Page created: February 04, 2025
Page updated: February 28, 2025
Page reviewed: February 28, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.